WORLD FEDERATION OF HEMOPHILIA

WFH 2012 World Congress

 

8-12 July, 2012 Paris, FRANCE
Close
N. Poster
Poster title
Applicant name
Status
  0-Mo Registry of Clotting Factor Concentrates Mark Brooker Received Received
  1-We Prevalence of Cardiovascular Disease or its Equivalents in Patients withInherited Coagulopathies M. CEM AR Received Received
  2-Mo Patterns of bleeding, comorbidities and clinical courses in Acquired HemophiliaA(AHA) and in Acquired von Willebrand Disease (AVWD): experience from a singleHemophilia Center of Pavia Gabriella Gamba Received Received
  2-We Carotid endarterectomy in two persons with Haemophilia Louise Bowles Received Received
  3-We DESCRIBING OCCURRENCE OF CORONARY EVENTS AND TREATMENT IN HAEMOPHILIACS (DOCETHREGISTRY): REPORT OF 27 PATIENTS. Antonio Coppola Received Received
  3-Mo Acquired hemophilia - clinical course and treatment outcomes in 25 patients Denisa Jankovicova Received Received
  4-LB Trends in invasive orthopedic interventions for individuals with a bleeding disorder enrolled in the Universal Data Collection Patricia Tobase Received Received
  4-Mo ACQUIRED HAEMOPHILIA AT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL MOOSA PATEL Received Received
  4-Tu INTEGRATING AGEING WITH A BLEEDING DISORDER INTO CANADIAN HEMOPHILIA SOCIETY(CHS) STRATEGIES Clare Cecchini Received Received
  5-We Cataract surgery in haemophilia Dietje Fransen van de Putte Received Received
  6-Tu THE IMPORTANCE OF MULTIDISCIPLINARY APPROACH TO PATIENTS WITH HEMOPHILIA Glbahar Keskin Received Received
  6-We Ageing and quality of life in persons with hemophilia Marko Marinic Received Received
  7-We Nursing the aging haemophiliac:Cardiovascular challenges Cathy Mumby Received Received
  7-Mo HIGH DOSE OF FVIII CONCENTRATE AS FIRST LINE THERAPY IN FOUR PATIENTS AFFECTEDBY ACQUIRED HAEMOPHILIA A AND CARDIOVASCULAR DISEASE Ezio Zanon Received Received
  7-Tu A Recruitment Plan for Volunteers Brian OMahony Received Received
  8-Tu Canadian Hemophilia Society Involvement in Canadas Blood System David Page Received Received
  8-We Newly emerging problems among aging patients with hemophilia in Japan Azusa Nagao Received Received
  9-We The Elderly Hemophilia Population - A Nordic Patient Organisation Prospective Suzanne Ceder Received Received
  10-We Patterns of gastrointestinal hemorrhage in hemophilia. ajmi naourez Received Received
  11-We The medical and economic burden of mild hemophilia in comparison to the severetype: long term data from a german single center Christoph Bidlingmaier Received Received
  12-Tu Prospective and challenges of pediatric hematology at KFSH&RC, Riyadh, Saudi Arabia MAHASEN SALEH Received Received
  12-We Technical issues in implementing prophylaxis in children with hemophilia: aninternational survey Christoph Bidlingmaier Received Received
  13-Tu Impact of training the trainers in haemophilia care in Pakistan Tahira Zafar Received Received
  14-Mo The European Haemophilia Network (EUHANET) project Michael Makris Received Received
  14-We CAUSES OF DEATH IN PATIENTS WITH HEMOPHILIA ATTENDED AT THE NATIONAL HEMOPHILIACENTER OF VENEZUELA (1989- 2011) Apsara Boadas de Sanchez Received Received
  15-Tu EXPERIENCE IN THE TREATMENT OF CUBAN PATIENTS WITH SEVERE BLEEDING USINGRECOMBINANT FVIIA Dunia de la Caridad Castillo González Received Received
  15-We CARDIAC SURGERY IN HAEMOPHILIACS : REPORT OF 14 CONSECUTIVE CASES Marie-Elisabeth Briquel Received Received
  16-Mo Patient Organisation involvement in management of Hepatitis C Brian OMahony Received Received
  17-Mo Muoviamoci (Italian Musculoskeletal Global Project) Gianluigi Pasta Received Received
  18-Mo Fostering collaboration in hemophilia care Jayson Stoffman Received Received
  19-We Evaluation of the utilization of factor concentrate and frequency of bleedsamong the patients with severe and moderate Factor VIII and Factor IX deficiency Roya Dolatkhah Received Received
  19-Mo Mild Haemophilia may hide severe haemophilia. Philippe BEURRIER Received Received
  20-Tu Variable Activation Kinetics of Different Recombinant Full Length and B-DomainDeleted Factor VIII Concentrates Saskia Pahl Received Received
  20-Mo Pregnancy outcome in haemophilia A carriers over a 5 year period in a UKHaemophilia Comprehensive care centre (CCC) Deepa Ranjani Jayakody Arachchillage Received Received
  21-We Usefulness of Multidetector Computed Tomography Angiography (MDCTA) inhemophilic patients previous to embolization of the middle geniculate artery(MGA) Matilde Hernandez-Trejo Received Received
  21-Tu One Year Clinical Experience with Mini-Pool Solvent/Detergent-filtered (SD-F)Plasma El Ekiaby Magdy Received Received
  23-We Comprehensive Spectrum of inherited bleeding disorders from South West Iran Bijan Keikhaei Received Received
  24-We Role of angiogram and embolisation in patients with haemophilia Shyamkumar Keshava Received Received
  25-Mo Hemophilia in Taiwan: a Population-Based Study on Epidemiology, Age atDiagnosis, Mortality, and 13-year Trend by National Health Insurance ResearchDatabase 1997-2009 Chia-Yau Chang Received Received
  25-Tu CTP - A CLINICALLY VALIDATED TECHNOLOGY FOR ELONGATING THE HALF LIFE OF COAGULATION FACTORS, ENABLING A PROLONGED HAEMOSTATIC ACTIVITY IN HEMOPHILIC ANIMAL MODEL Gili Hart Received Received
  26-We Obesity and Haemophilia - Review of an MDT weight management service. Paul McLaughlin Received Received
  29-Mo Updating the National Registry of People with clotting deficiencies in Mexico Carlos Gaitán-Fitch Received Received
  29-We Correcting Dilutional Coagulopathy in Haemophilia Renu Riat Received Received
  30-We Prevalence of sporadic and familial severe haemophilia: is anything changed? riccardi federica Received Received
  30-Tu Analysis of the Composition of a Factor VIII Concentrate, Optivate Sarah Kingsland Received Received
  31-We CLINICAL AND EPIDEMIOLOGICAL PROFILE OF CONGENITAL COAGULOPATHY PATIENTSATTENDING AT GENERAL EMERGENCY DEPARTMENT M. Angelica Rivera Received Received
  33-Mo Long-term course of the severe haemophilia A or B patients in Sweden: Results from a cohort register study Susanna Lvdahl Received Received
  33-Tu In vitro reversal of the direct Xa inhibitor Rivaroxaban using High Purityfactor X concentrate (FACTOR X) Joanne Lloyd Received Received
  34-Tu In vitro Characterisation of FACTOR X in Global Haemostasis Tests Joanne Lloyd Received Received
  34-Mo REALITY OF THE HEMOPHILIAS IN PANAMA MORENO BELGICA Received Received
  35-We Hemophilia in developing countries: clinical profile of Cameroonian patients Tayou Tagny Claude Received Received
  35-Mo Australian Bleeding Disorders Registry(ABDR) - an update Joihn Rowell Received Received
  36-Tu Repeated Application of a new Recombinant Factor IX in Rats and Macaques Eva Muchitsch Received Received
  37-Tu Preclinical Safety of a new Recombinant Factor VIIa Eva Muchitsch Received Received
  38-Tu Safety of a PEGylated variant of recombinant factor VIII after repeated application in rats and macaques Eva Muchitsch Received Received
  39-Tu Absorption, Metabolism, Distribution, and Excretion of a PEGylated Variant ofRecombinant Factor FVIII Following Intravenous Administration to Rats Eva Muchitsch Received Received
  39-We Intracranial bleeds in bleeding disorders: a Northern Pakistan experience Tahira Zafar Received Received
  40-Tu Pharmacokinetics (PK) of recombinant and plasma-derived factor VIII (FVIII) products in pediatric patients with severe hemophilia A Melanie Steele Received Received
  41-We The importance of the pediatric hemostaseologist:cohort of pediatrichemostaseology patients in a tertiary german out-patient center Sabine Irene Heine Received Received
  42-We Synoviorthesis with rifampicin as a adjuvant treatment of hemophilic arthropathy Pan Ru-Yu Received Received
  43-Tu Roman Numerals to Denote Clotting Factors: A Potential Source of Medical Errors David Page Received Received
  43-We Nutritional study in haemophilic patients by using social networks Gianluca Sottilotta Received Received
  43-Mo National plan of control of heamophilia. The Moroccan national plan El Khorassani Mohamed Received Received
  44-Mo Cost assessment of implementation of ITI in Iran PEYMAN ESHGHI Received Received
  44-Tu CRYOPRECIPITATE TRANSFUSION IN ON-PUMP CARDIAC SURGERY Katerina Pavenski Received Received
  44-We Experience on the management of malignancy in hemophilia patients. Paula Villaca Received Received
  45-Mo Evidence for mobilizing policy on hemophilia in India : I. Utility of hemophiliaregistry data from Maharashtra, 1989-2009 Anita Kar Received Received
  45-Tu Characterization of the binding properties of recombinant FVIII concentrateswith von Willebrand Factor Daniele Pillitteri Received Received
  46-Mo Evidence for mobilizing policy on hemophilia in India: II. An estimate of treatment gap in Maharashtra Anita Kar Received Received
  46-Tu Factor XIII levels in Haemophilia; Treatment Implications Ole Halfdan Larsen Received Received
  47-We Nutritional Intake and Bone Mineral Density in Boys with Severe Hemophilia. Cecily Bos Received Received
  47-Mo Indirect Costs Among Persons With Hemophilia B: Hemophilia Utilization Group Study Part Vb (HUGS Vb) Mimi Lou Received Received
  48-We Low Bone Mineral Density and Increased Fat Mass in Boys with Severe Hemophilia. Cecily Bos Received Received
  48-Tu Efficacy of a Recombinant Factor IX in Mouse Models of Hemophilia B Eva-Maria Muchitsch Received Received
  48-Mo Economic impact of an efficient inclusive national tender system for factorconcentrates Brian OMahony Received Received
  49-Tu Efficacy of a New Recombinant Factor VIIa in Animal Models of Hemophilia Eva-Maria Muchitsch Received Received
  49-Mo Characterising Excessive School and Work Absenteeism in Hemophilia A: Hemophilia Utilization Group Study Part Va (HUGS Va) Jiat Ling Poon Received Received
  50-Tu Efficacy of a PEGylated Variant of Recombinant Factor VIII in Mouse Models ofHemophilia A Eva-Maria Muchitsch Received Received
  50-Mo A NEW METHODOLOGY TO ASSESS UTILITY IN HAEMOPHILIA USING QUALITY OF LIFEMEASURES IN PARENTS AND CAREGIVERS: THE CAREGIVERS BURDEN STUDY silvia riva Received Received
  51-Mo COST OF IMMUNE TOLERANCE INDUCTION IN HEMOPHILIA A PATIENTS: RESULTS FROM THE ITER STUDY silvia riva Received Received
  52-Mo PHARMMACOECONOMIC EVALUATION WITH AN ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE(APCC) IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS (PRO-FEIBA STUDY) silvia riva Received Received
  52-Tu Collaborative Study for the Establishment of Korean Standard for Blood Products(Factor IX Concentrate) JiSuk Seo Received Received
  52-We Managing major surgical operations in a large haemophilia centre in NorthernIndia Naresh Gupta Received Received
  53-Mo COST OF ILLNESS ANALYSIS OF HAEMOPHILIA A: RESOURCES USE AND DIRECT COSTS INITALY Michele Schino Received Received
  53-Tu The stability of FVIII in cold condition Rahajuningsih Dharma Setiabudy Received Received
  54-Tu A case of inhibitor to factor IX in a two years old boy with severe congenitalhaemophilia B. skhiri rania Received Received
  55-Mo Budget impact of FVIII concentrates taking into account the incidence of de novoinhibitor formation in PTPs: a breakeven analysis applied to ADVATE in theItalian context. Giuseppe Turchetti Received Received
  56-Mo A cost-effective provincial redistribution system to prevent wastage of clottingfactor concentrates Sarah Crymble Received Received
  57-Tu 2D-DIGE As a Tool to Analyze Lot-to-Lot Consistency of Complex TherapeuticProducts Such As BAX 855, a PEGylated Recombinant FVIII Peter L. Turecek Received Received
  58-Tu Influence of expression of recombinant human ADAMTS13 in cell lines fromdifferent species on its glycosylation pattern and pharmacokinetics Peter L. Turecek Received Received
  58-Mo Antihemophilic factors (AH) : comparative analysis and monitoring of spending atthe University Hospital of Dijon ELODIE PHILIPPE Received Received
  59-Tu Establishment of a manufacturing process for recombinant human ADAMTS13retaining high specific activity Peter L. Turecek Received Received
  59-We Safety of continuous rFVIII-FS infusions via 8-hour 250cc 0.9 IV bag Angela Lambing Received Received
  59-Mo Disarray to Distinction: fast track restructuring of hemophilia care in HongKong. Wing Au Received Received
  60-Tu Susceptibility of von Willebrand factor from different mammalian species tocleavage by human recombinant ADAMTS13 Peter L. Turecek Received Received
  60-Mo Telemedicine in Haemophilia: Virtual Consultation for the haematologist atpatients home. JOSÉ ANTONIO AZNAR Received Received
  61-Mo A project to establish a clinical and social assistance infrastructure inAfghanistan Franco backhaus Received Received
  62-Tu Development of a large scale production process for BAX 855, a PEGylated rFVIIIproduct Peter L. Turecek Received Received
  63-Tu Functional characterization of BAX 855, a PEGylated recombinant FVIII Peter L. Turecek Received Received
  64-Tu Assessment of preclinical safety for BAX 326, Baxters recombinant human factorIX Peter Turecek Received Received
  65-Tu Structural characterization of BAX 855, a PEGylated recombinant FVIII Peter L. Turecek Received Received
  65-Mo How to manage a heamophilia treatment centre in an emergent country. TheMoroccan experience. El Khorassani Mohamed Received Received
  66-Mo A National Infrastructure for Rare Blood Disorders: An Evaluation of Staffing,Training and Services in the US Federally-supported Hemophilia Treatment Centers Ann Forsberg Received Received
  66-Tu Characterization of BAX 817 a recombinant FVIIa drug candidate Peter L. Turecek Received Received
  67-Tu Characterization of BAX 326 a recombinant human factor IX drug candidate Peter L. Turecek Received Received
  67-Mo Governing as governance in a NMO Daniel-Aníbal García-Diego Received Received
  68-Mo Unique just like you Eduardo Garzon Received Received
  68-Tu Safety of BAX 855, a polyethylene glycol (PEG) conjugated full-lengthrecombinant Factor VIII product Peter Turecek Received Received
  70-We Restorative dentistry and third molar surgery in patient with an inhibitor toFVIII. A case report. Bozidar Brkovic Received Received
  71-Tu Contribution of chromatography to virus and TSE removal in the FactorVIII/VWFOptivate process Peter Feldman Received Received
  71-Mo From nothing to comprehensive hemophilia care -an experience of Karnataka Hemophilia Society sandeep H S Received Received
  71-We Caries study, oral hygiene and changes on dental surfaces associated withfructose consumption in haemophilic patients and Von Willebrand Evelyn González de Delgado Received Received
  72-We A review of dental surgical operations in 64 patients from a large haemophiliacentre in Northern India Naresh Gupta Received Received
  72-Mo Strategic Advocacy program to involve Government in Hemophilia care: anexperience from India Suresha Hanagavadi Received Received
  73-Mo Collaborative Working: The Newcastle Initiative Chris James Received Received
  73-We Dental Surgery with minimal factor support update assessment of 120 patients Ian Hewson Received Received
  74-We A specialized dental care programme for people with congenital coagulopathiesoffered in the Hemophilia Unit of Vall dHebron Hospital Rafael Parra Received Received
  74-Mo Developing Recommendations for the UK Government on Haemophilia services & NHSReform Chris James Received Received
  74-Tu USE OF HIGH DOSES FVIII/ VON WILLEBRAND FACTOR CONCENTRATE IN A PATIENT WITHTYPE III VON WILLEBRAND DISEASE AND HIGH LEVEL INHIBITOR M Nieves Alonso Escobar Received Received
  75-Mo Encouraging positive change for people with bleeding disorders through a national awards scheme Chris James Received Received
  75-We Periodontal management of Malagasy hemophiliacs Simone RAKOTO ALSON Received Received
  76-Mo Asha Kiran - Summer camps to empower persons with hemophilia and their families. Annamma Joseph Received Received
  76-We Oral Health Status and Oral Health Related Quality of Life in IranianHemophilic Pediatric Patients Katayoun Salem Received Received
  77-Mo Kite flying - A unique idea for public awareness and fund raising. Experience from a rural hemophilia centre in India. Annamma Joseph Received Received
  77-Tu Adaptation in hemophilia A patients during long term prophylactic treatment Anna Balandina Received Received
  78-We A minimally invasive method for the diagnosis of lesions affecting the jaws Federico Stolbizer Received Received
  79-We DENTAL MANAGEMENT OF CHILDREN WITH BLEEDING DISORDERS - THE KUALA LUMPURHOSPITAL EXPERIENCE NORAINI NUN NAHAR YUNUS Received Received
  80-We Statistics of Dental Attention Provided to Pediatric Patients with Hemophiliaand Von Willebrand Disease at the Dental Clinic of the Hospital del Niño,Panama. SOL LAIZ TORRES Received Received
  80-Mo Australia and New Zealand Inhibitors Workshop: Meeting the Challenges Colleen McKay Received Received
  81-Tu Platelet procoagulant activity and thrombin generation in patients with severehemophilia Amy Dunn Received Received
  81-We Through an ethical lens: ethics, pain management and family centered care Liz Bishop Received Received
  81-Mo National educational programme in haemophilia in Ukraine Galyna Moroz Received Received
  82-Mo Hemophilia patient outreach: Experience of Vietnam Nguyen Thi Mai Received Received
  82-We Mothers of Children with Haemophilia: An Exploration of Their Experiences Simon Brown Received Received
  83-We Understanding the challenges of distance and parenting a child with Haemophilia Simon Brown Received Received
  83-Mo Twinning Programme between the Panamanian Foundation of Hemophilia and the CatalanAssociation of Hemophilia Felipe Ortega Received Received
  85-We Guidelines for Growing: An action plan for parents of children with bleedingdisorders Chad Feay Received Received
  85-Tu Concept Maps : an educational tool for teenagers with haemophilia ? Céline Chenuel Received Received
  85-Mo MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCYDEPARTMENT Gianna Franca Rivolta Received Received
  86-Mo Challenges Faced to Develop Comprehensive Hemophilia Care in India & its Remedies DEVILA SAHU Received Received
  87-Mo The HEMONLINE Project: preliminary results Gianluca Sottilotta Received Received
  89-We Re-PEP Programme in New Zealand - an opportunity to review, re-visit, reflectand refresh. Colleen McKay Received Received
  89-Mo Improved hemophilia care in developing countries through the World Federation ofHaemophilia twinning programmes: the case of Yaoundé and Geneva Tayou Tagny Claude Received Received
  89-Tu Evaluation of the therapeutic education of 35patients with hemophilia Amina Krim Received Received
  90-Tu Developing the design of a educational game for children with Hemophilia. MARCIA APARECIDA PICCOLOTO MATTA Received Received
  90-We Family issues faced by women with bleeding disorders and importance ofpsychological help in overcoming them Priyanka Rawat Received Received
  91-We FACTOR IX SECRETION IN HUMAN ADIPOSE-DERIVED STEM CELLS BY NON-VIRAL GENETRANSFER ANTONIO LIRAS Received Received
  91-Tu OPTIMIZE THE HEMOPHILIA ATTENTION, IN THE EMERGENCY ROOM, THROUGH A EDUCATIONMANUAL TO PRIMARY PHYSICIANS AND NURSES IN PANAMA MORENO BELGICA Received Received
  92-Tu Severe Bleeding Disorder Alert Cards Brian OMahony Received Received
  93-Tu MULTIDISCIPLINARY FORMATION AND TREATMENT IN HEMOPHILIA. A MEXICAN PILOT PROJECTCONTRIBUTION FROM THE HEALTH PSYCHOLOGY Maricela Osorio Received Received
  93-We The impact of home treatment in the management of hemophilia in developingcountries El Khorassani Mohamed Received Received
  93-Mo INTRACEREBRAL HEMORRHAGES IN PATIENTS WITH HEMOPHILIA: THREE YEARS OF FOLLOW-UPAT THE COMPREHENSIVE CARE PROGRAM IN CUBA (2008-2010). Dunia de la Caridad Castillo González Received Received
  94-Tu Dont Push Your LuckBoard Game for Childrens Decision Making in their Hemophilia Care Lisa Semple Received Received
  95-Tu HEMOPHILIA: TEACHING PROGRAM AT THE UNIVERSITY OF VALENCIA (SPAIN) QUEROL FUENTES FELIPE Received Received
  95-Mo Clinical outcome in a cohort of HIV/HCV coinfected patients. HCV RNA presenceassociated to higher GGT levels. Aloisi Zavala Natalia Received Received
  96-Mo Distribution of IL28b gene polymorphisms and presence of 32bp CCR5 deletion in acohort of HIV/HCV coinfected patients. Maria Cecilia Monzani Received Received
  96-Tu The Development of a Tool to Assist Patients in Identifying Health Care Coverage- Personal Health Insurance Toolkit Michelle Rice Received Received
  96-We Home clinical assistance: ITALIAN SURVEY OF HCA SUPPORT FOR THE MANAGMENT OF CVCIN PEDIATRIC HEMOPHILIC PATIENTS IN PROPHYLAXIS. Ezio Zanon Received Received
  97-Tu Pedagogical practices with the use of Informatics resources for people withHemophilia Cristiane Santos Received Received
  97-Mo Evaluation of liver fibrosis in haemophilia patients with HCV infection usingtransient elastography - Fibrotest. Angelika Batorova Received Received
  98-We Effect of in vivo induction of regulatory T cells forimmune toleristaion andeffect on FVIII inhibitor anamnestic response Simon Brown Received Received
  99-We Factor VIII product-dependent recognition of anti-factor VIII antibodies Saulius Butenas Received Received
  100-We HOW MANY PATIENTS WITH HIGH-RESPONDING INHIBITORS DO/DID NOT UNDERGO IMMUNETOLERANCE INDUCTION IN ITALY? WHY NOT? Antonio Coppola Received Received
  101-Tu NEW Teaching strategy: educational MANUAL of Hemophilia and VON WILLEBRAND forparents and patients in PANAMA. VILLALAZ LUZ Received Received
  101-We RISK OF BLEEDING AND INHIBITOR DEVELOPMENT AFTER CIRCUMCISION OF PREVIOUSLYUNTREATED(PUPs) OR MINIMALLY TREATED(MTPs) SEVERE HEMOPHILIA A PATIENTS Mohsen Elalfy Received Received
  102-Tu Development of an educational tool for haemophiliacs : advices of the pharmacist Anne-Sophie Leromain Received Received
  102-We Plasma-exchange and immunosuppressive therapy in a patient with mild hemophiliaA and inhibitors complicated by severe muscular bleeding and compartmentalsyndrome Chiara Ambaglio Received Received
  103-Mo The development of Japanese blood program for assuring safety in supplying domestic coagulation blood products: A case study of the Japanese Red Cross Society Masatake Hongo Received Received
  104-We Presence and evolution of anti-factor VIII (FVIII) catalytic activity in severe,mild or moderate hemophilia patients with FVIII inhibitors Sandrine Grosbois Received Received
  104-Tu Education: effective tool in the prevention of complications and appropriatemanagement of Haemophilias patient in Panama. FRNCO ANAYANSI Received Received
  105-Tu BENEFITS FROM WHF TWINNING AND TEACHING PROGRAMS,OUR EXPERIENCE. GUADALUPE VIVERO Received Received
  106-Mo Like a curse: Outcomes of the New Zealand 2011 People with Haemophilia andHepatitis C Survey Chantal Lauzon Received Received
  106-Tu Use of short message service (SMS) to document bleeding episodes in childrenwith haemophilia Carolyn Broderick Received Received
  107-Tu BLOOD 4 : A blog to cope with Hemophilia with the use of images Frederica R.M.Y cassis Received Received
  108-Tu Remote Control: Is it enough? Desdemona Chong Received Received
  111-Mo Number of Patients with Coagulation Disorders in Japans 2010 Annual Report fromthe Research Committee for the National Surveillance on Coagulation Disordersin Japan SHINOBU TATSUNAMI Received Received
  111-Tu Social Network for Girls and Women with Bleeding Disorders Cheryl DAmbrosio Received Received
  112-Mo The running infection of hepatitis C virus (HCV) diagnosis is too late in femalewith Severe Hereditary Clotting Factor Disorders (SHCFD): French single Centreexperience. peynet peynet Received Received
  113-Mo An attempt to analyze the narrative world of the life-stories of doctors andpatients involved in the HIV tainted blood product incident in Japan Masatake Hongo Received Received
  114-Mo Decrease of microparticles (MP) after the treatment in hemophilia A patients:Coincidence or causation? Jovan P Antovic Received Received
  114-Tu Role of Telemedicine in managing Bleeding disorders in rural Pakistan Tahira Zafar Received Received
  115-Mo Characterizing Global Hemostasis Throughout the FVIII Prophylaxis DosingInterval: A Pilot Study Donald Brophy Received Received
  116-Mo A CIRCULATING HEPARIN-LIKE ANTICOAGULANT WITH NO BLEEDING COMPLICATIONS: CASE REPORT Desiree Coen Herak Received Received
  117-Tu Successful Orthotopic Liver Transplantation in a Patient with Severe HaemophiliaA and High Titre Factor VIII Inhibitor Richard Gregg Received Received
  118-Mo Hemophilia A prenatal diagnosis by factor VIII clotting activity usingpercutaneous umbilical blood sampling Yunhai Fang Received Received
  119-Mo Haemophilia - a missed diagnosis Naresh Gupta Received Received
  119-We Successful Immune Suppression Followed by Immune Tolerance Induction in a Factor9 Patient Who had Developed an Anaphylactic Reaction to Factor 9. Nancy Hodgson Received Received
  119-Tu Life itself. Different visions of hemophilia Otilia Ragull Received Received
  120-Mo Investigation of a prolonged APTT: Date from a UK NEQAS for Blood Coagulationexercise Ian Jennings Received Received
  120-We Plasma Exchange and Continuous Infusion of Factor VIII for Life-Saving Surgeryin Hemophilia A with High-Titer Inhibitor: Two Case Reports Rungrote Natesirinilkul Received Received
  120-Tu Caring for Mild Hemophilia: A Challenge to Comprehensive Hemophilia TreatmentCenters M Dawn Goodyear Received Received
  121-We Successful low-dose immune tolerance induction regimen using multiple plasma-derived factor VIII concentrates. Marina Pereira Colella Received Received
  121-Tu Development and Evaluation of a Self-assessment Pathway for Young Men with Mild Hemophilia JoAnn Nilson Received Received
  122-Mo NEW QUANTITATIVE aPTT WAVEFORM ANALYSIS ON BEHRING COAGULATION SYSTEM Marija Milos Received Received
  122-We IgG4 subclass of anti-FVIII antibodies is correlated to high-titer inhibitor,whereas IgG1 subclass is related to low-titer inhibitor in hemophilia Apatients. Margareth Ozelo Received Received
  123-We Genetic risk factors for inhibitor development in a Brazilian severe hemophiliaA population Margareth Castro Ozelo Received Received
  123-Mo UTILITY OF NEW QUANTITATIVE aPTT WAVEFORM ANALYSIS IN LABORATORY MANAGEMENT OFHEMOPHILIA A PATIENTS Marija Milos Received Received
  124-Mo Validating the Role of Thrombelastography and the Thrombin Generation Assay forRoutine Clinical Care in Children with Haemophilia Manfred Rauh Received Received
  124-We Sequential therapy with activated prothrombin complex concentrate andrecombinant factor VIIa in the treatment of unresponsive bleeding in patientswith hemophilia and inhibitors in a single center experience Young Shil Park Received Received
  125-Tu The Royal Family: A Project to Increase Awareness of Hemophilia in Slovakia Jaroslav Janovec Received Received
  125-Mo Modified Inverse shifting-PCR (IS-PCR) to investigate Intron 22 Inversion federica riccardi Received Received
  126-Mo Molecular Analysis of mild haemophilia patients: the experience of a singlecentre federica riccardi Received Received
  126-Tu Cerebral hemorrhage in a Malagasy with haemophilia B AIMEE OLIVAT RAKOTO ALSON Received Received
  127-We Resolution of Nephrotic Syndrome Following Rituximab Therapy in a PatientUndergoing Immune Tolerance Induction Susan Kearney Received Received
  128-Tu Bile Acid deficiency as cause of VKCFD in a Newborn Matthias Watzka Received Received
  128-We Impact of HLA and cytokines polymorphisms on inhibitors development in childrenwith severe Haemophilia A Helen Pergantou Received Received
  129-Tu Benefits of an Individual Communication Strategy from a National Haemophilia Society Anne Duffy Received Received
  129-Mo Evaluation of Hemostatic Effect of BAY 86-6150, a Recombinant FVIIa Variant, inAntibody-Induced Hemophilic Whole Blood Under Flow Conditions Mitsuhiko Sugimoto Received Received
  130-We Experience of surgery in patients with haemophilia with inhibitors Tatiana Polyanskaya Received Received
  131-Mo Stability of clotting factors in fresh frozen plasma in the University TeachingHospital of Yaoundé, Cameroon Tayou Tagny Claude Received Received
  132-Mo Thromboelastography as screening test for the diagnosis of Scott Syndrome. paula villaca Received Received
  132-We Identification of potential T-cell epitopes in factor VIII using peptidemicroarrays Kathleen Pratt Received Received
  133-We A Canadian survey on the incidence and risk factors for inhibitor development insevere hemophilia A PUPs: 2005-2010. Georges-Etienne Rivard Received Received
  134-We F8 genotype and not polymorphisms in IL10, TNFA and CTLA4 influences inhibitor development in Argentine patients with severe HA. Liliana Rossetti Received Received
  135-We Circumcision experience in severe hemophilia patients with inhibitors Sasmaz Ilgen Received Received
  136-Mo Heterozygote frequencies of common polymorphic markers of factor VIII (F8) and factor IX (F9) genes in indigenous Nepali population Shrimati Shetty Received Received
  137-We Prospective ADVATE Immune Tolerance Induction Registry (PAIR) in Hemophilia APatients with Inhibitors: Interim Report Gerald Spotts Received Received
  138-We ALLELE POLYMORPHISMS OF IMMUNE RESPONSE GENES IN SEVERE HAEMOPHILIA A PATIENTSWITH INHIBITORS IN UKRAINE Oleksandra Stasyshyn Received Received
  138-Mo Various genetic mechanisms resulting in phenotypic expression of haemophilia A in three females Virginie Barbay Received Received
  139-We Case series report - low-dose immune tolerance (ITI) in Iran shirin Tehrani Tarighat Received Received
  140-Mo Duplications Xq28 and Hemophilia are questionable for genetic counselling Catherine Costa Received Received
  140-Tu Differences in the Bleeding Phenotypes of Haemophilia A and B Berthold Siegmund Received Received
  141-Mo Spectrum of mutations in 407 unrelated haemophilia B patients Costa Catherine Received Received
  143-Mo A third rearrangement caused by homologous recombination between inverted repeats at Xq28 cause severe hemophilia A Behnaz Pezeshkpoor Received Received
  145-Mo Inversion 22 in Hemophilia A in the North Indian Population: a New cDNA BasedProtocol Praveen Kumar Received Received
  145-We Genotype-phenotype Correlation in Hemophilia A and Risk of Inhibitors of F8 genemutations kiyoung yoo Received Received
  145-Tu The method of concentration of blood clotting factor VIII usingcross-galvanization in patients with hemophilia A Kate Kabaeva Received Received
  146-Tu A New Clinical Tool to Measure Balance and Mobility in Hemophilia: the CommunityBalance and Mobility Scale. Cecily Bos Received Received
  149-Mo INTRACELLULAR TRAFFICKING ANALYSIS OF C111Y AND C111S MUTATIONS IDENTIFIED INFACTOR IX FROM MEXICAN PATIENTS WITH SEVERE HEMOPHILIA B JOHANNA MANTILLA CAPACHO Received Received
  149-We Prevalence of inhibitor antibodies in the Mazandaran(North of Iran) haemophiliaA population. Hassan Mahmoodi Nesheli Received Received
  150-Mo GENETICS DEFECTS IN VON WILLEBRAND DISEASE. Rosario Pérez Garrido Received Received
  150-We USE OF FACTOR VIII CONCENTRATES IN LIFE-THREATENING BLEEDING IN HEMOPHILICPATIENTS WITH INHIBITOR Hugh C Kim Received Received
  150-Tu ADVATE HaEmophlia A Outome Database (AHEAD): A long-term registry focusing onjoint health outcomes and health-related quality of life Gerald Spotts Received Received
  151-Tu A Post-Authorisation Safety Surveillance of ADVATE, Recombinant Antihemophilic Factor, Plasma/Albumin-Free Method (rAHF-PFM) in Hemophilia A Jenny Chou Received Received
  151-We Intracranial Hemorrhage (ICH) in a 5-years-old Child with Severe Hemophilia Band Inhibitors with Anaphylaxis: Treatment Issues Carvalho Manuela Received Received
  151-Mo Absence of active F8 protein despite high F8 mRNA expression levels in a severeHaemophilia A patient Behnaz Pezeshkpoor Received Received
  152-We Prevalence of inhibitor in a prospective cohort of hemophilic children under 4years of age from a single center. Florencia Tisi Baña Received Received
  152-Mo IDENTIFICATION OF MUTATIONS ASSOCIATED WITH HAEMOPHILIA A: A FRENCH CARIBBEANEXPERIENCE Serge PIERRE-LOUIS Received Received
  152-Tu Estimated Annual Infusion Volume Reduction with a 2 mL Reconstitution Volume forADVATE josh epstein Received Received
  153-Mo The Canadian National Program for Hemophilia Mutation Testing database: aten-year anniversary review. Natalia Rydz Received Received
  153-We Successful use of negative pressure wound therapy in a patient with severeHemophilia A and an inhibitor Vicky Hanneman Received Received
  154-Tu Pain in Haemophilia. Assessment of type of pain, coping styles and analgesicuse. bj ramsay Received Received
  155-We RADIOACTIVE SYNOVECTOMY of the SHOULDER JOINT in PATIENTS with HAEMOPHILIA Semih Aydogdu Received Received
  155-Tu Pain and Meaning: from the injury to the experience of pain Ceres Lotito Received Received
  156-Mo Clinical implementation of Clinician-oriented locus specific mutation detectionand deposition system kiyoung yoo Received Received
  156-We The management of domiciliary acute haemarthrosis by ultrasonography: experiencein a single center. AZNAR LUCEA JOSE ANTONIO Received Received
  157-We Autologous stem cell treatment in hemophilic arthropathy. Aymara Baganet Cobas Received Received
  158-We KNEE ON FLEXION: OSTEOTOMY OF FEMORAL EXTENTION IN PEDIATRIC PATIENTS WITH HAEMOPHILIA ROBERTO BERNAL-LAGUNAS Received Received
  159-Mo Gene rearrangements and mutations in Malaysian patients with Haemophilia A maimiza zahari Received Received
  159-We Abnormal inter-extremity difference (AIED) of quadriceps muscle strength and relationship to patellar tendon thickness and joint status in PWH Alexander Brunner Received Received
  159-Tu Central Venous Line Insertion and Factor Replacement Therapy in Patients with Haemophilia A: a local experience. Adriana Fonseca Received Received
  160-Tu Obesity management in boys with severe haemophilia: What works? Nicola Hamilton Received Received
  161-Mo Role of nurse in improving hemophilia care Fayal Bouaballou Received Received
  162-Mo Inherited Bleeding Disorders- The Nursing Experience of Patient and Family CareNeeds in the Paediatric Setting. Gill Doyle Received Received
  163-Tu Constraints and challenges in treating a young haemophiliac with exceptionallyhigh inhibitor titers. Andromachi Papagianni Received Received
  163-Mo The needs and support measures of Japanese haemophilic careers(JHC): discussionfrom literature review. tomie fujii Received Received
  165-We Frequency , risk factors and consequences of Decreased Bone mineral Density inchildren with Hemophilia A and B PEYMAN ESHGHI Received Received
  165-Tu A Survey of Current Canadian Practice in the Care of Newborn Boys withHemophilia Paul Moorehead Received Received
  165-Mo Evaluation of methods of identifying carriers of haemophilia. Anne Gillham Received Received
  166-We Pseudotumours in mild haemophiliacs - a rare pathology. joanna farrant Received Received
  168-Mo Optimising health outcomes for childrenliving with Haemophilia in rural communitiesby forging partnerships betweenHaemophilia Treatment Teams and Local Health Networks Anne Jackson Received Received
  169-We Total Knee Replacement in patients with Hemophilia - a follow-up of 30 patients Bjoern Habermann Received Received
  170-We Autologous Chondrocyte Implantation in a patient with severe Hemophilia Bjoern Habermann Received Received
  172-Mo Using motivational interviewing techniques to enhance therapeutic relationshipswith adult and pediatric hemophilia clients Lois Logie Received Received
  172-We Iliopsoas haemorrhage in patients with haemophilia. Denisa Jankovic Received Received
  173-Mo A Successful Model of a Nursing Short Message System (SMS) for ImprovingHemophilia Care in South China Jing SUN Received Received
  173-Tu Preclinical safety pharmacology of a PEGylated variant of recombinant factor VIII Eva Muchitsch Received Received
  174-Tu Pharmacokinetics of a Recombinant Factor VIIa in Factor VIII ko Mice, Rats andMacaques Eva-Maria Muchitsch Received Received
  174-We ETPS - AN EFFECTIVE MODALITY IN CHRONIC SYNOVITIS TO ENHANCE ACTIVITY Dr. Jayashri Kale Received Received
  175-Tu Single Dose Pharmacokinetics of a PEGylated Variant of Recombinant FVIII inFactor VIII ko Mice, Rats and Macaques Eva-Maria Muchitsch Received Received
  175-We Factor IX (FIX) deficiency and a swollen knee: not always a bleed Susan Karp Received Received
  176-Tu Single Dose Pharmacokinetics of Recombinant FIX in Factor IX ko Mice, Rats andMacaques Eva-Maria Muchitsch Received Received
  176-Mo Networking in Hemophilia and other Bleeding Disorders Care:The Canada-Germany Nurse Experience Nancy Hodgson Received Received
  177-Tu Preclinical safety pharmacology of a new recombinant factor IX Eva Muchitsch Received Received
  178-Mo Self-modification of Regimens by Hemophilia Patients in Japan Kayoko Omura Received Received
  178-Tu Evolution of management of pregnancies at-risk for haemophilia in France in the last ten years: Impact of non-invasive foetal sex determination Catherine Costa Received Received
  179-We Radiosynovectomy in Chronic Recurrent Haemophilic Haemarthrosis: The NorthEastExperience. Munir Khan Received Received
  180-We Results of ankle prosthesis in patients with severe haemophilic arthropathy -follow up Manuela Krause Received Received
  180-Mo EXPERIENCE IN VENOUS CENTRAL CATHETER (PORT-A-CATH) IN PEDIATRICS, FORTREATMENT OF HEMOPHILIA AND VON WILLEBRAND DISEASE IN PANAMA. VILLALAZ LUZ Received Received
  181-Mo Experience of the use of Veinviewer for DIVA patients with hemophilia kiyoung yoo Received Received
  182-Mo Case report of Heart surgery of the patient with bleeding disorder roxana kabiri movahhed Received Received
  182-We Joint Preservation Post Ankle Arthrodesis in Hemophilia: A Review Heidi Lane Received Received
  182-Tu Observational study for improving adherence with prophylaxis in haemophilia KAGEHIRO AMANO Received Received
  183-We Outcomes in Activity, Participation and Body Structure Following AnkleArthrodesis in Persons with Hemophilia: Analyses Using the Universal DataCollection Surveillance Project Heidi Lane Received Received
  183-Mo QUALITY OF LIFE FOR PATIENTS WITH HEMOPHILIA Glbahar Keskin Received Received
  184-We Intra-Articular Hyaluronic Acid in Treating of Haemophilic Knee Arthropathy Tsung-Ying Li Received Received
  184-Tu SECONDARY PROPHYLAXIS IN ADULT SEVERE HAEMOPHILIC PATIENTS: A PROSPECTIVE STUDYIN A SINGLE CENTER. JOSÉ ANTONIO AZNAR Received Received
  185-Mo Study of adherence to prophylactic treatment in severe A haemophilic patients JOSÉ ANTONIO AZNAR Received Received
  185-Tu Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling of Factor VIII (FVIII) Usingits Plasma Concentration and Global Hemostasis Biomarkers: Donald Brophy Received Received
  185-We Haemophilic Arthropathy and Health-Related Quality of Life in Haemophilic Patients in Taiwan Tsung-Ying Li Received Received
  186-Tu COMPARISON TWO LABORATORY ASSAYS IN MONITORING EFFICACY OF DIFFERENTPROPHILAXIS REGIMENS FOR SEVERE HAEMOPHILIA Irena Djunic Received Received
  187-Tu Successful Secondary Prophylaxis in Haemophilia with Inhibitors using rFVIIaThree Times per Week Monica Martinez Received Received
  188-Tu Bleeding Patterns In Severe Hemophilia A Infants and Toddlers On Prophylaxis VsOn Demand Therapy:A Prospective Randomized Observational Study Mohsen Elalfy Received Received
  188-We SUBPERIOSTEAL/INTRAMUSCULAR PSEUDOTUMOUR- SURGICAL TREATMENT BY INTRALESIONALCURRETTAGE OR WIDE EXCISION SHUBHRANSHU MOHANTY Received Received
  189-We Hemarthrosis results in an increase in Synovial Fibrinolytic activity in Hemophilia Mice laurens nieuwenhuizen Received Received
  189-Mo Multicenter study of pediatric quality of life and psychomotor development inparents of children with severe and moderate hemophilia who receive primaryprophylaxis treatment in public hospitals in Chile Claudia Bularte Received Received
  190-We Identification - and differences in expression - of the iron regulatorsFerroportin, Hepcidin, Hemoglobin Scavenger Receptor CD163, Heme Carrier Protein1, and Heme Exporter FLVCR in Healthy, Osteoarthritic, Rheumatoid, andHemophilic Synovium. Laurens Nieuwenhuizen Received Received
  190-Mo The Impact of Pediatric Psychology on Identification of Psychosocial Needs Cathliyn Buranahirun Received Received
  191-Mo Pedagogical attention programme. Results after 18 year s experience. Patricia Cabré Received Received
  192-Tu Adherence to Prophylaxis Treatment Regimens among Persons with Severe Hemophilia A and B: Results from a 1-Year, Single Institution Study Miguel Escobar Received Received
  192-Mo Social Participation in Boys with Hemophilia Aubrey Chiu Received Received
  193-We Prospective Evaluation of Safety and Efficacy of Radioactive Synovectomy with90Yttrium-Hidroxyapatite and 153Samarium-Hidroxyapatite in Chronic HemophilicSynovitis JANAINA BOSSO J SILVA Received Received
  193-Tu Prophylaxis with increasing doses, our experience about 8 cases FAIZA MEZHOUD Received Received
  194-We Conservative Treatment of Severe Knee Flexion Contracture in Two Patients withSevere Hemophilia A Patients with High-responding Inhibitors Margareth Ozelo Received Received
  195-We Surgical treatment of the hemophilic pseudotumor:a single center experience Joannis Panotopoulos Received Received
  195-Mo Childhood and subjective timings: growing up with hemophilia Silvia Grases Received Received
  196-Mo Psycho-social issues in haemophilia- 100 case studies Naresh Gupta Received Received
  196-Tu SECONDARY PROPHYLAXIS IN HEMOPHILIAC ADULTS WITH ARTHROPATHY. DESCRIPTION OF ACOHORT. Carlos Ramírez Received Received
  197-Tu SECONDARY PROPHYLAXIS WITH ANTI INHIBITOR COAGULANT COMPLEX (AICC): FROMANECDOTE TO REALITY Maria Helena Solano Received Received
  197-Mo :Psychosocial Issues-support for People With Hemophilia & their families inIndia: Meera Suresh Hanagavadi Received Received
  198-Tu Tailored primary prophylaxis with dose-escalation in Iranian haemophilia A shirin Tehrani Tarighat Received Received
  198-Mo THE PSYCHOLOGY WORK AT CENTRO DOS HEMOFLICOS DO ESTADO DE SO PAULO - CHESP Reiko Hanashiro Received Received
  199-We ULTRASONOGRAPHY PROTOCOL FOR DIAGNOSIS AND CONTROL OF ACUTE HEMARTHROSIS INHAEMOPHILIC PATIENTS QUEROL FUENTES FELIPE Received Received
  200-We Does prophylaxis have an effect on bone strength beyond physical activity? Anne Mkipernaa Received Received
  201-Tu Long-term low-dose secondary prophylaxis for severe and moderate hemophiliachildren with arthropathy: A single-center prospective study in China Ada Xu Received Received
  202-Tu Hemophilic arthropathy in pediatric patients with hemophilia A: comparison ofearly and late prophylaxis. kiyoung yoo Received Received
  202-Mo Restructuring and improving QOL in Japanese HIV victims with hemophilia andtheir families: How do we rebuild our life with effective support? Akiko Kakinuma Received Received
  203-We Bone mineral density in hemophiliac patients Nader Roushan Received Received
  204-Tu Prophylaxis vs. On Demand Treatment in Adults with Severe Hemophilia A. Cecily Bos Received Received
  206-Mo Mind Inhibitors Walid Kobisi Received Received
  206-Tu What do Canadian men living with Hemophilia need to know to facilitate optimaldisease management? A mixed methods approach Shannon Lane Received Received
  207-Tu The Effect of yoga technique on quality of life in children and adolescentswith haemophilia referring to Dastgheib hospital .1389 Shiraz University OfMedical Siences SHIRAZ-IRAN Noushin Beheshtipoor Received Received
  208-We Long-term studies of hemophilic arthropathy by Petterssons score - Evidencesthat joint damages in hemophiliacs occur predominantly in early years of life Ming-Ching Shen Received Received
  208-Mo A NEW TOOL TO ASSESS COPING AND PERCEPTION OF CHILDREN WITH HAEMOPHILIA Perrine Limperg Received Received
  209-Mo HEALTH RELATED QUALITY OF LIFE OF BOYS WITH HAEMOPHILIA AND PARENTS ILLNESS PERCEPTIONS Perrine Limperg Received Received
  210-We Age-related changes of joint status in adults with severe haemophilia in Germany Franziska Staeuber Received Received
  211-Mo Social support and economic stability as major determinants of self-esteem amongpersons with hemophilia Marko Marinic Received Received
  211-Tu Quality of life of hemophilic children on prophylactic or on demand treatmentregimens in Iran PEYMAN ESHGHI Received Received
  212-Tu The Place of the Pictorial Blood Assessment Chart in the appreciation of qualityof life in women with inherited bleeding disorders. Anis Fadhlaoui Received Received
  212-We Osteochondral lesions of the ankle joint in patients with hemophilia A. A retrospective case series. Karen Strike Received Received
  213-Tu Quality of life during menstruations in women with inherited bleeding disorders(About 31 patients) Anis Fadhlaoui Received Received
  213-Mo A 10-year follow up of an HIV/HCV co-infected hemophilia A after living donorliver transplantation Eiichi Mizukoshi Received Received
  214-Mo At a loss as to where to go from here? Daryl Pollock Received Received
  215-We Arthroscopic synovectomy with joint distraction using a patella tendon bearingbrace for severe hemophilic ankle arthropathy YASUHITO TANAKA Received Received
  215-Mo Oral Mucosal Bleeding: A Nurses View bj ramsay Received Received
  216-Tu FACTORS RELATED TO QUALITY OF LIFE IN HEMOPHILIA PATIENTS. Miwa Goto Received Received
  216-We Radiosynovectomy with Yttrium and Samarium. 488 patients/842 injections. Preliminary report on radiation safety Sylvia Thomas Received Received
  216-Mo Youth With Hemophilia In Pakistan Sheikh Moin Riaz Received Received
  217-Tu Health Related Quality of Life Among Hemophilia Patients in North East Region ofIndonesia Stefanus Gunawan Received Received
  217-We Blood coagulation aggravates joint damage after an experimental hemorrhage in acanine knee Monique van Meegeren Received Received
  218-We Four-day continuous blood exposure leads to prolonged joint damage in a caninein vivo model, whereas intermittent blood exposure does not Monique van Meegeren Received Received
  219-Mo Psychosocial Issues and support for PWH & their families in India Meera Suresh Hanagavadi Received Received
  220-Mo COMPARATIVE STUDY OF FUNCTIONING FAMILY IN PATIENTS WITH HEMOPHILIA AND OTHERFAMILIES WITH DISEASE Ana Torres-Ortuño Received Received
  221-Mo SCHOOLS OF FAMILIES FOR PARENTS OF CHILDREN WITH HEMOPHILIA Ana Torres Received Received
  223-We Experimental evaluation of cartilage damage by hematic synovitis in rabbits byNuclear Magnetic Resonance control Ana Laura Douglas Price Received Received
  223-Mo The Psychologic and Disease burden assessment in hemophilia children witharthropathy: a single-center study in China Ada Xu Received Received
  223-Tu PATIENT REPORTED OUTCOMES IN CLINICAL HAEMOPHILIA PRACTICE Perrine Limperg Received Received
  224-We PRELIMINARY RESULTS OF A PHYSIOTHERAPY PROTOCOL IN THE SECONDARY PROPHYLAXIS OFADULTS WITH HAEMOPHILA QUEROL FUENTES FELIPE Received Received
  224-Tu Income and Anxiousness of Working Hemophiliacs in Japan Takeshi Matsumoto Received Received
  225-Tu Treatment outcome in young adults survey of 8 Countries - Preliminary Results Brian OMahony Received Received
  226-Mo Auto care for childrens YURI ANDREA ARANGO BERNAL Received Received
  227-Tu HEALTH RELATED QUALITY OF LIFE (HrQoL) IN BLEEDING PROPHYLAXIS WITH AN ACTIVATEDPROTHROMBIN COMPLEX CONCENTRATE (APCC): RESULTS FROM THE PRO-FEIBA STUDY silvia riva Received Received
  227-Mo ECONOMIC AND PSYCHO-SOCIAL CARE FOR HAEMOPHILIA PATIENTS IN MARTINIQUE, A FRENCHCARIBBEAN EXPERIENCE Serge PIERRE-LOUIS Received Received
  228-Tu Linking Quality of Life Measures with the ICF/ICF-CY in Young People withHaemophilia silvia riva Received Received
  228-Mo Screening of the Von Willebrand disease in the west Algeria. BENLALDJ DRISS Received Received
  229-We A baseline assessment of physical disabilities in 372 haemophilia patients inNorthern India Naresh Gupta Received Received
  229-Tu Difficulties faced by haemophilic students in Japan Yukiko Seki Received Received
  230-Tu Description of a Canadian Cohort of Youth and Young Men with Hemophilia Based onHealth-Related Quality of Life Measures. Jean St-Louis Received Received
  230-We Hemophilia at Physical Medicine and Rehabilitation, assessment of physical,functional and psychological aspects: Prospective study conducted at Oran hospital - Algeria khaled layadi Received Received
  231-Mo SINGLE CENTRE EXPERIENCE OF THE GP1B LATEX IMMUNOASSAY AND RISTOCETIN COFACTOR ASSAY - A COMPARATIVE STUDY. David Davies Received Received
  231-Tu Impact of Life Events and Transitions on Health-Related Quality of LifeMeasurements in Youth and Young Adults with Hemophilia. Jean St-Louis Received Received
  232-Tu Quantitative word mapping of hemophiliac patients opinions based on free-answerdescriptions on a quality-of-life questionnaire SHINOBU TATSUNAMI Received Received
  232-We Assessment of Functional Independence Score In Hemophilia in Indian Children with Hemophilia Sandeep H S Received Received
  233-Mo PARAPROTEIN SPECIFIC BINDING FOR PLATELET RECEPTOR GLYCOPROTEIN Ib AS A CAUSE OFACQUIRED VON WILLEBRAND SYNDROME IN MONOCLONAL GAMMOPATHIES Irena Djunic Received Received
  234-Tu Understanding the Impact of Hemophilia on the Family: A Pilot Study of thePedsQL-Family Impact Module Vicky Breakey Received Received
  234-Mo Expression Studies of von Willebrand Factor Missense Mutations Causing Type 1 orType 2 VWD Hamideh Yadegari Received Received
  235-Tu Has the quality of life improved for children with haemophilia A? Vaughan Williams Received Received
  236-We Strength training and stretching muscles of lower limbs in patients withhemophilia and arthropathy of the ankle. A pilot study. RUBÉN CUESTA-BARRIUSO Received Received
  236-Tu HAEMO-QOL QUESTIONNAIRE FOR ADOLESCENTS: ASSESSING THE ITEM BLEEDING Claudia Lorenzato Received Received
  237-Tu QUALITY OF LIFE IN RELATION TO SOCIAL AND EMOTIONAL SELF CONCEPT AND LIFE SATISFACTION Luis Vañó Gisbert Received Received
  237-We Efficacy and safety of traction articular ankle arthropathy. A pilot study RUBEN CUESTA-BARRIUSO Received Received
  238-We Clinical improvement of chronic arthropathy of the knee with manual therapy. Apilot study. RUBÉN CUESTA-BARRIUSO Received Received
  238-Tu Swimming as a strategy to promote rehabilitation, physical fitness, mentalhealth and social inclusion to people and families suffering of Hemophilia andVon Willebrand. YURI ANDRES ARANGO BERNAL Received Received
  238-Mo A pregnant woman with von Willebrand disease (VWD) type 2B: laboratory findingsand peripartal bleeding management Katharina Holstein Received Received
  239-We In-hospital rehabilitation after multiple joint procedures (MJP) of the lowerextremities in persons with hemophilia (PWH) Piet Kleijn, de Received Received
  239-Tu Psychometric properties of the Quality of Life Questionnaire in PediatricPatients with Hemophilia Mexico (QoLHMEX) Maricela Osorio Received Received
  240-Tu Online Anthology of Individual Experiences by Girls and Women with BleedingDisorders Cheryl DAmbrosio Received Received
  240-Mo Clinical diagnosis and laboratory screening in vWD pediatric patients of theNorthwestern of Mexico Ana Rebeca Jaloma-Cruz Received Received
  240-We The Use of a Carbon-fiber Ankle Foot Orthosis and Therapeutic Exercise forManaging Pain in An Adolescent with Severe Blood-induced Ankle Joint ArthropathySecondary to Type 3 von Willebrand Disease Sharon Funk Received Received
  241-We Recovery of the gait ability after total knee arthroplasty Minoru Kubota Received Received
  242-Mo On demand therapy after ITT failure in a patient with von Willebrand diseasetype 3 and alloantibodies Manuela Krause Received Received
  243-We Use of the Exergaming (Nintendo Wii) in the Rehabilitation of Patients withHemophilia. JANAINA BOSSO JOSÉ DA SILVA Received Received
  243-Tu Prophylactic treatment in factor XI deficiency patients undergoing invasiveprocedures. Philippe BEURRIER Received Received
  244-We Postural control in children with hemophilia. Fabio Souza Received Received
  245-We Successful treatment outcome for an eight year old hemophilia boy withChronic Regional Pain Syndrome (CRPS) Rachel Tiktinsky Received Received
  245-Tu Rare Inherited Bleeding Disorders: from a single centre in Pakistan. MUNIRA BORHANY Received Received
  246-Tu Mutations causing severe Factor XIII deficiency in Pakistan MUNIRA BORHANY Received Received
  247-Mo Prevalence of von Willebrand disease in Koreans Sangkyu Park Received Received
  247-We The effect of 8-week aquatic exercise on Strength, Balance and Gait speed inhemophilia kiyoung yoo Received Received
  248-We Improvement of walking ability of three inhibitors by rehabilitation shimokawa akikko Received Received
  249-Mo Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease. Natalia Rydz Received Received
  250-Tu The Canadian Experience: Severe Factor V Deficiency M Dawn Goodyear Received Received
  251-We Serial casting on deformity with excercises is more effective than conventionalphysiotherapy treatment in people with hemophilia Geeta Suri Received Received
  252-We THE OXIDATIVE STRESS AND ANTIOXIDANT STATUS AT CHILDREN WITH IMMUNETHROMBOCYTOPENIC PURPURA: ENDOTHELIAL NITRIC OXIDE SYNTHASE Glu298Asp GENEPOLYMORPHISM Saadet Akarsu Received Received
  253-Mo Molecular Pathology of severe von Willebrand disease in Indian population Shrimati Shetty Received Received
  253-We NORMAL PLATELET PARAMETERS IN CHILDHOOD PERIOD FROM NEWBORNS TO ADOLESCENTS Saadet Akarsu Received Received
  253-Tu Laboratory Diagnosis of FXIII deficiency: Data from a UK NEQAS (BloodCoagulation) exercise Ian Jennings Received Received
  254-Mo Polymorphic markers in VWF gene: Application in genetic diagnosis of affectedfamilies with VWD Shrimati Shetty Received Received
  255-We Hemarthrosis an Unusual Presentation of Glanzmanns thrombasthenia Bijan Keikhaei Received Received
  256-Tu Inherited Factor VII deficiency - perioperative replacement therapy is notnecessary in most cases Robert Klamroth Received Received
  256-Mo Development of an automated VWF:RCo assay for measuring plasma samples with lowactivity Peter L. Turecek Received Received
  257-Mo Analysis of the French cohort of 65 patients with type 2N von Willebrand diseaseidentifies distinct molecular/clinical entities. Agnès VEYRADIER Received Received
  258-Mo French cohort of 37 patients with type 3 von Willebrand disease: molecular andclinical features Agnès VEYRADIER Received Received
  258-We Identification of 5 new mutations in 9 Glanzmann Thrombasthenia patients Ann-Kathrin Pilgrimm-Thorp Received Received
  259-Tu Factor XIII deficiency in Sistan and Baluchestan of Iran Majid Naderu Received Received
  260-Tu Frequency & clinical spectrum of rare bleeding disorder in Pakistan,A multi centre study Arshi Naz Received Received
  260-We Neurosurgery in a patient with Bernard-Soulier Syndrome Elianna Saidenberg Received Received
  261-Mo Persistent acquired von Willebrand disease cases despite underlying neoplasmaremission. Maria Eva Mingot Castellano Received Received
  261-Tu PROPHYLACTIC TREATMENT WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE IN APATIENT WITH SEVERE FACTOR X - FX- DEFICIENCY. Jorge Peña Siado Received Received
  262-We 5 years Treatment report of hospitalized children with Glanzmannsthrombasthenia in a comprehensive hemophilia care center (2006-2011) PEYMAN ESHGHI Received Received
  262-Tu Phenotypic classification of the mutations in coagulation factor IX segregate to different locations in its protein structure Pavithra Meena Rallapalli Received Received
  262-Mo Thrombosis in patients with von Willebrands disease Mirjana Mitrovic Received Received
  263-Mo Pregnancy outcomes in women with, and carriers of, inherited bleeding disordersin a London obstetric unit with Haemophilia Comprehensive Care Centre. Imelda Balchin Received Received
  264-Tu Genotype-Phenotype correlation in families with mild factor VII deficiency federica riccardi Received Received
  265-Mo CODEROUGE 2012 - 1st CANADIAN CONFERENCE ON BLEEDING DISORDERS IN WOMEN Clare Cecchini Received Received
  265-We Physical and psychosocial benefits of exercise for patients with haemophilia Lisa Blain Received Received
  266-We Haemophilia & Exercise Project (HEP): Subjective and objective physical performance in adult haemophilia patients after one year sports therapy programme Doerte Czepa Received Received
  268-Tu THROMBOSIS OF THE ABDOMINAL AORTA IN CONGENITAL AFIBRINOGENEMIA. Maria Teresa sartori Received Received
  268-We Development of a bleeds risk calculator Rob Herbert Received Received
  269-Mo Current Postpartum Treatment Strategies for Von Willebrand Disease May NotAdequately Replace von Willebrand Factor Andra James Received Received
  269-Tu Efficacy of a Recombinant ADAMTS13 in a Mouse Model of ThromboticThrombocytopenic Purpura Eva-Maria Muchitsch Received Received
  270-Mo Pregnancy outcome of women with congenital bleeding disorders managed bymultidisciplinary team in a UK Haemophilia Comprehensive care centre over 3-yearperiod DEEPA ARACHILLAGE Received Received
  270-Tu Delayed vitamin k deficiency related bleeding : is it genetically linked ? Shrimati Shetty Received Received
  270-We Patterns of physical activity in Australian children with haemophilia. Jane Latimer Received Received
  271-Tu Intracranial hemorrhage in an infant with severe Factor V deficiency Jayson Stoffman Received Received
  271-We Quantifying the challenge: Proposal for evaluation of musculoskeletal system inswimmers with hemophilia undergoing intensive training. MARIA MATILDE ROSAS CHACON Received Received
  272-Tu Factor XI deficiency: importance of von Willebrand factor level on haemorrhagicphenotype. Fabienne VOLOT Received Received
  272-We Importance of Youth Groups in an National Member Organization MUKESH GARODIA Received Received
  274-Mo Haemostatic Variations in Normal Women: The Role of Electronic Bleeding Questionnaire, Electronic Pictorial Chart and a Global Haemostatic Assay in Predicting Mild Bleeding Disorders in Women Kimberly MacEachern Received Received
  274-We Understanding health and treatment decision making among youth with hemophilia:a qualitative approach Shannon Lane Received Received
  275-We Participation of Children in National Haemophilia Conferences Brian OMahony Received Received
  275-Mo Hematological and Gynecological Assesment in Haemophilia Carriers Carlos Ramírez Received Received
  276-Mo Successful IVF and pregnancy in Glanzmanns thrombasthenia under cover of recombinant factor VIIa Peter Staritz Received Received
  276-Tu Molecular analysis of congenital factor XI deficiency by High-Resolution Melting federica riccardi Received Received
  277-Mo A Strategy for Women with Bleeding Disorders The Irish Experience Debbie Greene Received Received
  277-We A Feasibility Study of Managing Hemophilia Online, An Internet-basedself-management and transitional care program for teens. Vicky Breakey Received Received
  278-Tu Are They Really Rare?Prevalence of Rare Bleeding Disorders (RBDs) in North East of Iran Zahra Badiei Received Received
  279-We Patients attitude to dental care Andrew Brewer Received Received
  296-LB Evaluation of a 4-year External Quality Assessment Program on the Laboratory Diagnosis of Hemophilia in Brazil Silmara Aparecida Lima Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Fri 8:00-15:00
18:56
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image

WORLD FEDERATION OF HEMOPHILIA

WFH 2012 World Congress

 

8-12 July, 2012 Paris, FRANCE
HELP LINE
Sponsored by:

Manage Orders
FAQs


Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 08/07/2012 TO 12/07/2020
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.WFH2012.2012 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 07/07/2012
Upload Poster
Upload Oral Presentation of Video
Check your Poster
Upload
Poster
Upload Oral
Presentation or Video
Check
your Poster

Sponsored by:















PosterSessionOnline
Logo Draft
 
Logo Cert